www.evvolve.io Open in urlscan Pro
34.249.200.254  Public Scan

Submitted URL: https://alliesfilinggroup.com/
Effective URL: https://www.evvolve.io/
Submission: On August 14 via automatic, source certstream-suspicious — Scanned from DE

Form analysis 2 forms found in the DOM

Name: wf-form-Newsletter-FormGET

<form id="wf-form-Newsletter-Form" name="wf-form-Newsletter-Form" data-name="Newsletter Form" method="get" class="footer-form" data-wf-page-id="6601ea47f497e4b319acc379" data-wf-element-id="e1ab56b7-f9bf-0870-916d-44c1aabf9973"
  aria-label="Newsletter Form"><input class="email-form w-input" maxlength="256" name="email-2" data-name="Email 2" placeholder="email" type="email" id="email-2" required="">
  <div class="submit-wrapper">
    <div class="footer-arrow-wrapper"><img loading="lazy" src="https://cdn.prod.website-files.com/6601ea47f497e4b319acc372/66a511717f78e27bf12cf631_Arrow%201%20(7).svg" alt="" class="footer-arrow"></div>
    <div>Submit</div><input type="submit" data-wait="Please wait..." class="submit-button w-button" value="">
  </div>
</form>

Name: email-formGET

<form id="email-form" name="email-form" data-name="Email Form" method="get" class="footer-form" data-wf-page-id="6601ea47f497e4b319acc379" data-wf-element-id="b10040a0-161c-0761-44e3-6dc115e89dbc" aria-label="Email Form"><input
    class="email-form w-input" maxlength="256" name="email-2" data-name="Email 2" placeholder="email" type="email" id="email-2" required="">
  <div class="submit-wrapper">
    <div class="footer-arrow-wrapper"><img loading="lazy" src="https://cdn.prod.website-files.com/6601ea47f497e4b319acc372/66a511717f78e27bf12cf631_Arrow%201%20(7).svg" alt="" class="footer-arrow"></div>
    <div>Submit</div><input type="submit" data-wait="Please wait..." class="submit-button w-button" value="">
  </div>
</form>

Text Content

VISIONTEAMCOMMITMENTSINSIGHTSCONTACT US
LINKEDIN
X
VISIONTEAMCOMMITMENTSINSIGHTSCONTACT US



CONNECTING YOU WITH THE RIGHT INVESTORS

Vision


WHY WE STARTED EVVOLVE

At Evvolve, our mission is to empower venture capitalists, high net worth
individuals, and family offices to discover promising investment opportunities
with precision.




COMMITMENTS

Explore our history of deals, reflecting our commitment to transformative
investment opportunities.


View All
View All


THE FIRM

Our mission at Evvolve is to connect disruptive entrepreneurs with strategic
capital, ensuring growth and innovation.

Meet Our Team

EVVOLVE

EVVOLVE

EVVOLVE

EVVOLVE



INSIGHTS

All News
August 12, 2024
3min


MERGERS, MIND CONTROL, AND MEDICAL BREAKTHROUGHS: THE WEEK'S TOP HIGHLIGHTS

From mind-controlling implants to billion-dollar mergers, this week's biotech
breakthroughs read like science fiction—except they're very real.

Read
July 23, 2024
3min


REDEFINING POSSIBILITIES: BREAKTHROUGHS IN NEUROTECHNOLOGY AND IMMUNOLOGY

This week's highlights showcase advancements in AI-driven research, innovative
funding strategies, and cutting-edge biocomputing technologies that are
revolutionizing the field.

Read
July 12, 2024
3min


$200 MILLION SPEAKS: WHY INVESTORS ARE BETTING ON AI-POWERED DRUG DISCOVERY

The biotechnology landscape continues to evolve at a breakneck pace, with
groundbreaking developments reshaping the future of healthcare and drug
discovery.

Read
July 6, 2024
4min


SILICON VALLEY MEETS LIFE SCIENCES: AI, GENE EDITING, AND STRATEGIC PARTNERSHIPS

Exciting developments are reshaping the landscape of biotechnology and
healthcare innovation.

Read
August 12, 2024
3min


MERGERS, MIND CONTROL, AND MEDICAL BREAKTHROUGHS: THE WEEK'S TOP HIGHLIGHTS

From mind-controlling implants to billion-dollar mergers, this week's biotech
breakthroughs read like science fiction—except they're very real.

Read
July 23, 2024
3min


REDEFINING POSSIBILITIES: BREAKTHROUGHS IN NEUROTECHNOLOGY AND IMMUNOLOGY

This week's highlights showcase advancements in AI-driven research, innovative
funding strategies, and cutting-edge biocomputing technologies that are
revolutionizing the field.

Read
July 12, 2024
3min


$200 MILLION SPEAKS: WHY INVESTORS ARE BETTING ON AI-POWERED DRUG DISCOVERY

The biotechnology landscape continues to evolve at a breakneck pace, with
groundbreaking developments reshaping the future of healthcare and drug
discovery.

Read
All News
NEW YORK

99 Wall StreetNY 10005, United States

DUBAI

The Grand, Ras Al KhorDubai Creek Harbour, UAE

HAMBURG

Neuer Jungfernstieg 620354 Hamburg, Germany

LONDON

71-75 Shelton StreetWC2H 9JQ, United Kingdom

BOSTON
‍
MIAMI
NEWSLETTER
Find out first about hot deals and trends.
Submit
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
LINKEDIN
Privacy Policy
X
Terms of Service
VISIONTEAMCOMMITMENTSINSIGHTSCONTACT US

Securities are offered through Finalis Securities LLC Member FINRA / SIPC.
Evvolve & Partners LLC is not a registered broker-dealer, and Finalis Securities
LLC and Evvolve & Partners LLC are separate, unaffiliated entities. Finalis
Privacy Policy | Finalis Business Continuity Plan | FINRA BrokerCheck

evvolve.io (the “Evvolve & Partners LLC Website”) is a website operated by
Evvolve & Partners LLC, a privately held Wyoming limited liability company.
Evvolve & Partners LLC provides, financial and strategic advisory, consulting
services, mergers and acquisitions services, and capital raising services.

© Evvolve & Partners 2024
VISIONTEAMCOMMITMENTSINSIGHTSCONTACT US
LINKEDIN
X
NEWSLETTER
Find out first about hot deals and trends.
Submit
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Privacy PolicyTerms of Service
NEW YORK

99 Wall Street
NY 10005, United State

DUBAI

The Grand, Ras Al Khor
Dubai Creek Harbour, UAE

HAMBURG

Neuer Jungfernstieg 6
20354 Hamburg, Germany

LONDON

71-75 Shelton Street
WC2H 9JQ, United Kingdom

BOSTON

MIAMI

Securities are offered through Finalis Securities LLC Member FINRA / SIPC.
Evvolve & Partners LLC is not a registered broker-dealer, and Finalis Securities
LLC and Evvolve & Partners LLC are separate, unaffiliated entities. Finalis
Privacy Policy | Finalis Business Continuity Plan | FINRA BrokerCheck

evvolve.io (the “Evvolve & Partners LLC Website”) is a website operated by
Evvolve & Partners LLC, a privately held Wyoming limited liability company.
Evvolve & Partners LLC provides, financial and strategic advisory, consulting
services, mergers and acquisitions services, and capital raising services.

© evvolve & partners 2024